Comparative study of chemoradiation and neoadjuvant chemotherapy effects before radical hysterectomy in stage IB-IIB bulky cervical cancer and with tumor diameter greater than 4 cm

International Journal of Gynecological Cancer

Volumn 15, Issue 3, 2005, Pages 483-488

  Modarress, M ^a   Maghami, F Q ^a   Golnavaz, M ^a   Behtash, N ^a   Mousavi, A ^a   Khalili, G R ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cervical cancer; Chemoradiation; Neoadjuvant chemotherapy; Radical hysterectomy

Indexed keywords

CISPLATIN; CREATININE; LIVER ENZYME; VINCRISTINE;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOVAGINAL FISTULA; DERMATITIS; FEMALE; HUMAN; HYDRONEPHROSIS; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; NAUSEA; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; SQUAMOUS CELL CARCINOMA; STOMATITIS; URETER STENT; URINARY TRACT INFECTION; UTERINE CERVIX CARCINOMA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS; VINCRISTINE;

EID: 18944362631     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.15312.x     Document Type: Article

References (20)

1. Disaia PJ, Creasman WT. Invasive cervical cancer. In: Disaia PJ, Creasman WT, eds. Clinical gynecology oncology. St. Louis, MO: Mosby, 2002:53-80.
2. Disaia PJ, Creasman WT. Pre invasive disease of the cervix. In: Disaia PJ, Creasman WT, eds. Clinical gynecology oncology. St. Louis, MO: Mosby, 2002:1-34.
3. Jurado M, Martinez-Monge R, Garcia-Foncillas J et al. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer. Gynecol Oncol 1999;74:30-7.
4. Duenas-Gonzalez A, Cetina L, Mariscal I, de la Garza J. Modern management of locally advanced cervical carcinoma. Cancer Treat Rev 2003;29:389-99.
5. Green JA, Kirwan JM, Tierney JF et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358:781-6.
6. Tierney JF, Stewart LA. Neoadjuvant chemotherapy followed by radiotherapy for locally advanced cervix cancer: a meta-analysis using individual patient data from randomised controlled trials [abstract]. Proc ASCO 2002;21:207a. Abstract 824.
7. Stewart LA, Tiernay JF. Neoadjuvant chemotherapy and surgery versus standard radiotherapy for locally advanced cervical cancer: a meta-analysis using individual patient data from randomised controlled trials [abstract]. Proc ASCO 2002;21:207a. Abstract 825.
8. Shimizu Y. Consecutive low-dose cisplatin-based chemotherapy for gynecologic malignancies. Gan To Kagaku Ryoho 1997;24:431-8.
9. Aoki Y, Tanaka K. Current approaches of neoadjuvant chemotherapy in cervical cancer. Expert Rev Anticancer Ther 2002;2:73-82.
10. Moore DH. Treatment of stage IB2 (bulky) cervical carcinoma. Cancer Treat Rev 2003;29:401-6.
11. Sardi JE, Sananes CE, Giaroli AA et al. Neoadjuvant chemotherapy in cervical carcinoma stage UB: a randomized controlled trial. Int J Gynecol Cancer 1998;8:441-50.
12. Benedetti-Panici P, Greggi S, Colombo A et al. Neoadjuvant chemotherapy and radical survey versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 2001;20:179-188.
13. Yamakawa Y, Fujimura M, Hidaka T et al. Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer. Gynecol Oncol 2000;77:264-70.
14. Moore DH. Neoadjuvant chemotherapy for cervical cancer. Expert Opin Pharmacother 2003;4:859-67.
15. Pignata S, Silvestro G, Ferrari E et al. Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix. J Clin Oncol 1999;17:756-60.
16. Hwang YY, Moon H, Cho SH et al. Ten-year survival of patients with locally advanced, stage Ib-IIb cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 2001;82:88-93.
17. Krivak TC, Mcbroom JW, Elkas JC. Cervical and vaginal cancer. In: Berek JS, ed. Novak's gynecology. 13th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2002:1199-237.
18. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A et al. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol 2003;14:1278-84.
19. Kodama J, Ikuhashi H., Hongo A et al. Neoadjuvant chemotherapy for advanced cervical cancer. Gan to Kagaku Ryoho 1999;26:89-92.
20. Kim DS, Moon H, Kim KT et al. Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor. Gynecol Oncol 1989;33:225-30.